Genedata strives to facilitate knowledge sharing and engaging discussions on best practices in the field of NGS-Based Biosafety Testing and Cell Line Development.
By registering using the form below, you can now stay up to date on future open forum events!
Genedata Selector has already co-hosted four successful open forum events with leading biopharma companies. With Bristol Myers Squibb (BMS) we hosted events focused on NGS-based biosafety testing on:
- December 10th, 2020
- September 16th 2021
- January 27th 2022
These events featured talks by experts on the key challenges and opportunities in the field. They covered NGS-based adventitious virus detection, its impact in accelerating timelines, the benefits of its implementation during biopharma R&D, and regulatory practices.
Previously, we hosted an event focused on Cell Line Development (CLD) on April 29th, 2021 together with Boehringer Ingelheim. It provided a platform for experts to share their experiences in cell line characterization and multi-omics data integration and analysis. Other important themes discussed included the applications of NGS in CLD and digitalization.
To date, these events have been an opportunity for knowledge sharing and engaging discussions to share best practices in the field. To continue the exchange of ideas, we will host these events regularly,touching on important subjects in the NGS-based biosafety testing and Cell Line Development domains.
Please register below to receive information on upcoming events and indicate your specific interests.
We look forward to you joining us at a future Open Forum!